Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haller, C.
Right arrow Articles by Kübler, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haller, C.
Right arrow Articles by Kübler, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1999) 14: 2582-2584
© 1999 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

The disappointing results of PTCA in the uraemic patient—are stents the answer?

Christlieb Haller and Wolfgang Kübler

Department of Internal Medicine, Division of Cardiology, University of Heidelberg, Heidelberg, Germany

Correspondence and offprint requests to: Priv. Doz. Dr C. Haller, Department of Internal Medicine III, University of Heidelberg, Bergheimerstr. 58, 69115 Heidelberg, Germany.

Introduction

Patients with renal failure, especially patients with end-stage renal disease, have high cardiovascular morbidity and mortality, to a large extent due to coronary artery disease. As a result uraemic patients frequently undergo coronary intervention, but the long-term outcome of percutaneous transluminal coronary angioplasty (PTCA) has been disappointing, mainly because of accelerated re-stenosis. A re-stenosis rate of up to 81% after initially successful PTCA has been reported, and even higher rates for repeat angioplasties [1]. In another study the 5-year cardiac-event-free rate was 70% in dialysis patients treated with coronary artery bypass grafting compared with only 18% in patients who had received PTCA [2. . . [Full Text of this Article]

Role of antiplatelet therapy

Can stents improve the outcome of PTCA in uraemic patients?

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?